FDA Import Refusal 1FX-1577805-2/10003/1 — NANJING HANXIN INTERNATIONAL
The FDA refused shipment 1FX-1577805-2/10003/1 from NANJING HANXIN INTERNATIONAL (China) on May 19, 2026. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charges: 2280,3902
Refusal Details
- Date
- May 19, 2026
- Country
- China
- Product Category
- Drugs and Biologics
- Product Code
- 61PCT72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 2280,3902